Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
New England Journal of Medicine (2025) The REDEFINE 1 Phase 3 trial was a landmark 68-week, double-blind, randomized study comparing CagriSema (cagrilintide 2.4 mg plus semaglutide 2.4 mg) with semaglutide alone, cagrilintide alone, and placebo in 3,417 adults with obesity or overweight without diabetes
Cost Reduction Strategies Ranked by Savings Strategy | Estimated Annual Savings | Effort Level | Who Qualifies --- | --- | --- | --- Private insurance coverage (80%) | $1,900 to $3,450 | Medium (enrollment) | Employed Canadians with group benefits Provincial drug plan (if listed) | $1,500 to $3,000 | Low (apply once) | Low-income residents, seniors in some provinces Novo Nordisk savings card | $360 to $600 | Low (sign up online) | All Canadian patients without public coverage Switch to online pharmacy ( $0 dispensing) | $100 to $156 | Low (transfer Rx) | Anyone with a valid prescription Costco pharmacy pricing | $80 to $150 | Low (shop there) | Anyone (no membership needed for pharmacy) 90-day fills vs
DOWNLOAD NOW Transforming Lives Through Functional and Regenerative Medicine
these funds were not used to support these studies
doi: 10.1016/j.jdiacomp.2012.12.007 179 ZayaniYAllal-ElasmiMJacobMPZidiWFtouhiBFekiMet al
Indicates manufacturing in a facility following strict quality regulations
